Ingrand D, Briquet I, Babinet J M, Reinert P, Huraux J M
Clin Pediatr (Phila). 1985 Nov;24(11):660-3. doi: 10.1177/000992288502401118.
Two children aged 7 months with eczema herpeticum received treatment consisting of intravenous acyclovir and human plasma with a high titer of herpes simplex virus antibodies. One recovered following two recurrences, but the other died rapidly, suffering both septicemia due to Pseudomonas aeruginosa and herpetic encephalitis. In both cases, the virus involved was a herpes simplex virus type 1 (HSV 1). The various isolates obtained before, during and after treatment remained equally sensitive to acyclovir. These observations highlight three points: the unpredictable and sometimes dramatic development of eczema herpeticum in the young child; the urgency of early diagnosis and treatment; the role of environment in viral contamination.
两名7个月大的疱疹样湿疹患儿接受了由静脉注射阿昔洛韦和含有高滴度单纯疱疹病毒抗体的人血浆组成的治疗。一名患儿在两次复发后康复,但另一名患儿迅速死亡,死于铜绿假单胞菌败血症和疱疹性脑炎。在这两个病例中,所涉及的病毒均为1型单纯疱疹病毒(HSV 1)。治疗前、治疗期间和治疗后获得的各种分离株对阿昔洛韦仍同样敏感。这些观察结果突出了三点:幼儿疱疹样湿疹不可预测且有时会急剧发展;早期诊断和治疗的紧迫性;环境在病毒污染中的作用。